Cargando…
Ocular side effects of novel anti-cancer biological therapies
To examine the ocular side effects of selected biological anti-cancer therapies and the ocular and systemic prognosis of patients receiving them. We retrospectively reviewed all medical records of patients who received biological anti-cancer treatment from 1/2012 to 12/2017 and who were treated at o...
Autores principales: | Vishnevskia-Dai, Vicktoria, Rozner, Lihi, Berger, Raanan, Jaron, Ziv, Elyashiv, Sivan, Markel, Gal, Zloto, Ofira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803740/ https://www.ncbi.nlm.nih.gov/pubmed/33436995 http://dx.doi.org/10.1038/s41598-020-80898-7 |
Ejemplares similares
-
Anterior chamber infiltration of CAR T-cells
por: Jacoby, Elad, et al.
Publicado: (2021) -
Amelanotic conjunctival melanoma in a child
por: Vishnevskia-Dai, Vicktoria, et al.
Publicado: (2022) -
Ocular Manifestations of Leukemia and Results of Treatment with Intravitreal Methotrexate
por: Vishnevskia-Dai, Vicktoria, et al.
Publicado: (2020) -
Uveitis prior to clinical presentation of Multiple Sclerosis (MS) is associated with better MS prognosis
por: Raskin, Eyal, et al.
Publicado: (2022) -
Primary Vitreoretinal Lymphoma Masquerading as Refractory Retinitis
por: Zloto, Ofira, et al.
Publicado: (2015)